Sylvain Chemtob, University of Alberta

Research

Allosteric Receptor Antagonist Commercialization Health Canada And Food And Drug Administration Human Fetal Membranes Interleukin-1 Beta Investigational New Drug Meeting Mouse Newborn Inflammation

Latest funding

Prolonging gestation and improving newborn outcomes with a novel IL-1 receptor modulator
CIHR · 2024 · Principal investigator
$1,269,901
Integrated discovery studies and commercialization for a preterm birth diagnostic and a therapeutic
CIHR · 2020 · Co-investigator
$558,450
Prevention of preterm birth (PTB) and fetal inflammation (FI): the pharmacology and toxicology of targeting interleukin (IL)6 with HSJ633, a small peptide allosteric IL6 receptor antagonist
CIHR · 2019 · Co-investigator
$1,120,726

All 5 grants and awards

Prolonging gestation and improving newborn outcomes with a novel IL-1 receptor modulator

Principal investigatorCIHR2024Project Grant

Principal investigators: Olson, David M; Chemtob, Sylvain

Keywords: Allosteric Receptor Antagonist; Commercialization; Health Canada And Food And Drug Administration; Human Fetal Membranes; Interleukin-1 Beta; Investigational New Drug Meeting; Mouse; Newborn Inflammation; Pre-Clinical; Preterm Birth

$1,269,901

Integrated discovery studies and commercialization for a preterm birth diagnostic and a therapeutic

Co-investigatorCIHR2020Project Grant

Principal investigators: Olson, David M

Keywords: Commercialization; Diagnostic; Preterm Birth; Therapeutic

$558,450

Prevention of preterm birth (PTB) and fetal inflammation (FI): the pharmacology and toxicology of targeting interleukin (IL)6 with HSJ633, a small peptide allosteric IL6 receptor antagonist

Co-investigatorCIHR2019Project Grant

Principal investigators: Olson, David M

Keywords: Allosteric; Efficacy; Fetal Inflammation; G-Proteins; Interleukin 6; Newborn Health; Pharmacology; Preterm Birth; Receptors; Toxicology

$1,120,726

The role of interleukin-1 beta in preterm birth diagnosis and treatment

Co-investigatorCIHR2019Project Grant

Principal investigators: Olson, David M

Keywords: Diagnostics; Interleukin 1; New Drugs; Parturition; Preterm Birth; Therapeutics

$1,067,175

The pivital roles of IL1B and IL6 in the timing of birth

Co-investigatorCIHR2011Operating Grant

Principal investigators: Olson, David M

Keywords: Humans; Interleukins; Leukocytes; Mice; Myometrium; Preterm Birth; Receptor Antagonists

$609,489

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for

Mention their CIHR grant from 2024

Subject: Prospective PhD student: Allosteric Receptor Antagonist Dear Professor Chemtob, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. Your research on allosteric receptor antagonist connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] I also saw your CIHR-funded project "Prolonging gestation and improving newborn outcomes with a novel IL-1 receptor modulator" (2024), and I would be glad to contribute to work in that direction. Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]